Literature DB >> 27249722

Liver Metastases in Colorectal Cancer.

Gunnar Folprecht1.   

Abstract

Resection of colorectal liver metastases is a treatment standard because patients experience long-term disease-free survival or are even cured after undergoing this procedure. Improved surgical techniques for liver resection in combination with downsizing liver metastases by chemotherapy, interventions to induce liver hypertrophy before resection, and the use of ablative techniques have allowed us to expand the indications for liver surgery and local treatment in situations with limited metastatic colorectal cancer. Resectability and identification of patients who might benefit from liver surgery and local ablative techniques are key factors for the treatment of patients with colorectal cancer. Despite the wide acceptance of liver surgery and ablative techniques, there are many open questions on the management of limited metastatic disease, such as which patients benefit from an aggressive surgical approach, what the indications for ablative and other local techniques are, and what the role of chemotherapy is for patients with resectable or resected disease. Unfortunately, results of randomized trials are only available for a limited number of these questions.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27249722     DOI: 10.1200/EDBK_159185

Source DB:  PubMed          Journal:  Am Soc Clin Oncol Educ Book        ISSN: 1548-8748


  5 in total

1.  Anti-cancer effect of Aquaporin 5 silencing in colorectal cancer cells in association with inhibition of Wnt/β-catenin pathway.

Authors:  Wei Wang; Qing Li; Tao Yang; Dongsheng Li; Feng Ding; Hongzhi Sun; Guang Bai
Journal:  Cytotechnology       Date:  2018-02-17       Impact factor: 2.058

Review 2.  Current state of the art imaging approaches for colorectal liver metastasis.

Authors:  Bita Hazhirkarzar; Pegah Khoshpouri; Mohammadreza Shaghaghi; Mounes Aliyari Ghasabeh; Timothy M Pawlik; Ihab R Kamel
Journal:  Hepatobiliary Surg Nutr       Date:  2020-02       Impact factor: 7.293

3.  Predictive And Prognostic Value Of Hepatic Steatosis In Conversion Therapy For Colorectal Liver-limited Metastases: A Propensity Score Matching Analysis.

Authors:  Mi Jian; Wenju Chang; Li Ren; Tianyu Liu; Yijiao Chen; Ye Wei; Qi Lin; Jianmin Xu; Xinyu Qin
Journal:  Cancer Manag Res       Date:  2019-09-11       Impact factor: 3.989

Review 4.  Novel Use of Low-Dose Radiotherapy to Modulate the Tumor Microenvironment of Liver Metastases.

Authors:  Kewen He; Hampartsoum B Barsoumian; Genevieve Bertolet; Vivek Verma; Carola Leuschner; Eugene J Koay; Ethan B Ludmir; Ethan Hsu; Esha Pisipati; Tiffany A Voss; Nahum Puebla-Osorio; Maria Angelica Cortez; James W Welsh
Journal:  Front Immunol       Date:  2021-12-15       Impact factor: 7.561

5.  Clinical analysis of ultrasound-guided radiofrequency ablation for recurrent colorectal liver metastases after hepatectomy.

Authors:  Xiao-Xiang Fan; Shu-Yi Lv; Mei-Wu Zhang; Xiao-Yu Dai; Jian-Pei Zhao; Da-Feng Mao; Yan Zhang
Journal:  World J Surg Oncol       Date:  2020-04-20       Impact factor: 3.253

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.